Basic Information
Vectura is a provider of innovative inhaled drug delivery services, enabling partners to bring their medicines to patients. With distinctive proprietary technology and drug development expertise, Vectura is one of the few global companies with the devices, formulations, and development capabilities to deliver a wide range of complex inhaled therapies. Vectura has 13 major inhaled products and 11 non-inhaled products, which are sold by partners generating global royalty revenues, and has a portfolio of partnered drugs in clinical development.
Vectura Group Ltd
England,United Kingdom
101~500 people
January 01, 1997
info@vectura.com

